Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1490 of 6351
-
Gene clue could lead to surgical cure for some high blood pressure patients
Knowledge-focused By invitation onlyPrimary aldosteronism (PA) is a known but underdiagnosed cause of high blood pressure. It is estimated that more than 10% of all people with high blood pressure (HT) suffer from PA, which is often caused by aldosterone-producing adrenal cortical tumors (APAs). In a pilot study w…
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
One-Week brain zaps aim to ease PTSD and pain in veterans
Symptom relief Not yet recruitingThe ANCHOR study is testing a novel, non-invasive brain stimulation program designed specifically for Veterans experiencing concurrent post-traumatic stress disorder (PTSD) and chronic pain. These conditions often occur together and can greatly impact daily life. Current treatmen…
Phase 4 • Sponsor: Legion Veterans Village Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can cannabis calm the brain? new study scans Veterans' brains for clues
Knowledge-focused By invitation onlyThis study will be the first to use brain imaging to explore how cannabis affects the brain and inflammation in U.S. military veterans with PTSD. It builds on an ongoing study testing different combinations of THC and CBD in 200 veterans. In this project, up to 100 veterans will …
Sponsor: Wayne State University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a nerve drug speed burn healing? new trial aims to find out
Disease control Recruiting nowMany patients suffer from traumatic burns and current treatments do not increase the regenerative potential of either skin grafts or the remaining uninjured skin. There is a need to develop treatments to accelerate and improve healing of burn injuries. More research is needed to …
Phase 2 • Sponsor: John Elfar • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New triple therapy takes on hard-to-treat ovarian cancer
Disease control Not yet recruiting\*\*Primary Objective:\*\* The primary objective of this study is to evaluate the efficacy and safety of liposomal irinotecan in combination with sintilimab and anlotinib in patients with recurrent or persistent ovarian clear cell carcinoma (OCCC). \*\*Treatment Regimen:\*\* Pa…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a simple supplement boost rectal cancer treatment?
Disease control Recruiting nowThis study is a prospective phase II clinical trial aimed at exploring the potential benefits of supplementing β-hydroxybutyrate with existing short course radiotherapy sequential immunotherapy and CAPEOX therapy.
Phase 2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New PET scan could sharpen detection of neuroendocrine tumors
Diagnosis Not yet recruitingThe study aims to elucidate how 18F-Octreotide PET/CT or PET-MR can assist in accurate localization, treatment planning, prognostic predictions, and the selection of PRRT efficacy in neuroendocrine tumors. It also highlights important applications in lesion segmentation measureme…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New cocktail aims to tackle rare lymphoma without chemo
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Zanubrutinib, Rituximab, and Lenalidomide works to treat marginal zone lymphoma as the first-line therapy. It will also learn about the safety of the treatment. The main questions it aims to answer are Does the combined therapy prolo…
Sponsor: Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Glowing dye guides surgeons to precise liver cancer removal
Disease control Recruiting nowThis prospective, single-arm exploratory study evaluates the feasibility and safety of a novel ICG-Cisplatin self-assembled nanoprobe (NIR-II NanoM) for fluorescence-guided surgery in patients with Hepatocellular Carcinoma (HCC). Participants will receive a transarterial injectio…
Early phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Experimental cell therapy takes on lupus in early trial
Disease control Not yet recruitingACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment in subjects with Relapsed/Refractory Systemic lupus erythematosus (SLE)
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Glowing dye could guide safer cancer surgery
Diagnosis Not yet recruitingSentinel lymph nodes, as the primary site of tumor metastasis, play a pivotal role in assessing patient prognosis and planning subsequent treatment strategies. The investigators plan to conduct a multicenter, prospective cohort study to evaluate the effectiveness of indocyanine g…
Phase 3 • Sponsor: Fujian Medical University Union Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Red light therapy tested to stop Kids' eyesight from worsening
Disease control Not yet recruitingThe goal of this clinical trial is to verify the effectiveness and safety of non-laser LED red light combined with defocus lens therapy for controlling myopia progression and evaluate the impact of different intervention durations in 6-14 years old children and adolescents with m…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for kids with rare kidney disease: telitacicept vs. steroids
Disease control Not yet recruitingTo further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this study employs a multicenter, retrospective and prospective observational research design. It aims to compare the efficacy of…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Zapping the brain to fight opioid cravings: new study tests TMS
Symptom relief Recruiting nowThe main purpose of this study is to learn how stimulating a region in the brain influences craving and opioid use. The brain will be stimulated using TMS. Participants may choose to receive brain imaging (magnetic resonance imaging, MRI) as part of this study. The MRI will be us…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
AI brain boost: new training may sharpen memory after stroke
Symptom relief Recruiting nowThis study would answer the following question:Does AI application-based training improve cognitive function in Patients with Stroke? The aims of this study: To investigate the efficacy of AI application-based training on cognitive function in stroke patients.
Sponsor: Omima Alaa Eldin Hussein • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Could a 3-Day diet boost stomach cancer treatment?
Disease control Recruiting nowConsistent with previous literature, the investigators postulate that a leucine-restricted diet is safe and well-tolerated in gastric cancer patients receiving neoadjuvant chemo-immunotherapy. Furthermore, the investigators propose that this dietary regimen promotes the activatio…
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New CT scan could predict heart attack Survivors' future risk
Knowledge-focused Recruiting nowAcute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide. Although percutaneous coronary intervention (PCI) combined with guideline-directed medical therapy has substantially improved survival, many patients continue to experience adverse cardi…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New ACP3 scan could spot prostate cancer better
Diagnosis Recruiting nowThe objective of the study is to construct a noninvasive approach ACP3 targeted PET/CT to detect tumor lesions in patients with prostate cancer and to compare with PSMA/FDG PET/CT.
Sponsor: Guilin Medical University, China • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Could a sticky patch on your chest predict heart failure relapse?
Knowledge-focused OngoingHeart failure (HF) is a growing global public health concern. Worldwide, the estimated prevalence of HF has increased to \>64.3 million cases. Despite improvement in outcomes with medication, HF is a leading cause of hospitalization among individuals \>65 years. Approximately 30-…
Sponsor: University of Monastir • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Placental clues: do progesterone receptors influence gestational diabetes?
Knowledge-focused OngoingThe aim of this study is to investigate the potential roles of PGRMC1, PGRMC2, and PAQR family membrane progesterone receptors in the pathophysiology of gestational diabetes mellitus by comparing their expression levels in placentas from pregnancies complicated by gestational dia…
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC